Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Feb;183(2):221-9.
doi: 10.1111/cei.12706. Epub 2015 Nov 9.

Activating PI3Kδ mutations in a cohort of 669 patients with primary immunodeficiency

Affiliations
Case Reports

Activating PI3Kδ mutations in a cohort of 669 patients with primary immunodeficiency

M Elgizouli et al. Clin Exp Immunol. 2016 Feb.

Abstract

The gene PIK3CD codes for the catalytic subunit of phosphoinositide 3-kinase δ (PI3Kδ), and is expressed solely in leucocytes. Activating mutations of PIK3CD have been described to cause an autosomal dominant immunodeficiency that shares clinical features with common variable immunodeficiency (CVID). We screened a cohort of 669 molecularly undefined primary immunodeficiency patients for five reported mutations (four gain-of-function mutations in PIK3CD and a loss of function mutation in PIK3R1) using pyrosequencing. PIK3CD mutations were identified in three siblings diagnosed with CVID and two sporadic cases with a combined immunodeficiency (CID). The PIK3R1 mutation was not identified in the cohort. Our patients with activated PI3Kδ syndrome (APDS) showed a range of clinical and immunological findings, even within a single family, but shared a reduction in naive T cells. PIK3CD gain of function mutations are more likely to occur in patients with defective B and T cell responses and should be screened for in CVID and CID, but are less likely in patients with a pure B cell/hypogammaglobulinaemia phenotype.

Keywords: B cells; PI3Kδ; common variable immunodeficiency; hypogammaglobulinaemia; primary immunodeficiency.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Spectrum of bronchial disease in family A siblings. Chest computed tomography (CT) scans of siblings 1, 2 and 3 (a,b,c) showing minimal bronchiectasis in sibling 1 (a), moderate bronchiectasis in sibling 2 (b) and unaffected lung tissue in sibling 3 (c).
Figure 2
Figure 2
Lung disease in sporadic patient 1 (SP1). Axial chest computed tomography (CT) scans of SP1 demonstrating pronounced bronchiectasis, mediastinal lymphadenopathy, peribronchial inflammation but no interstitial disease.
Figure 3
Figure 3
Massive splenomegaly in sporadic patient 1 (SP1). Ventral (a) and lateral (b) images of abdomen in SP1 showing massive splenomegaly.
Figure 4
Figure 4
Lung disease in sporadic patient 2 (SP2). Axial chest computed tomography (CT) scans of SP2 demonstrating mucus impaction of the left middle lobe, moderate bronchiectasis, interstitial disease and enlargement of mediastinal lymph nodes.

References

    1. Al‐Herz W, Bousfiha A, Casanova JL et al Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front Immunol 2014; 5:162. - PMC - PubMed
    1. Grimbacher B, Hutloff A, Schlesier M et al Homozygous loss of ICOS is associated with adult‐onset common variable immunodeficiency. Nat Immunol 2003; 4:261–8. - PubMed
    1. Vanhaesebroeck B, Welham MJ, Kotani K et al P110delta, a novel phosphoinositide 3‐kinase in leukocytes. Proc Natl Acad Sci USA 1997; 94:4330–5. - PMC - PubMed
    1. Kok K, Geering B, Vanhaesebroeck B. Regulation of phosphoinositide 3‐kinase expression in health and disease. Trends Biochem Sci 2009; 34:115–27. - PubMed
    1. Okkenhaug K. Signaling by the phosphoinositide 3‐kinase family in immune cells. Annu Rev Immunol 2013; 31:675–704. - PMC - PubMed

Publication types

MeSH terms

Substances